These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 34119682)

  • 1. Correspondence on "prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection".
    Mungmunpuntipantip R; Wiwanitkit V
    Ann Hepatol; 2021; 25():100360. PubMed ID: 34119682
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.
    Mendizabal M; Ridruejo E; Piñero F; Anders M; Padilla M; Toro LG; Torre A; Montes P; Urzúa A; Gonzalez Ballerga E; Silveyra MD; Michelato D; Díaz J; Peralta M; Pages J; García SR; Gutierrez Lozano I; Macias Y; Cocozzella D; Chavez-Tapia N; Tagle M; Dominguez A; Varón A; Vera Pozo E; Higuera-de la Tijera F; Bustios C; Conte D; Escajadillo N; Gómez AJ; Tenorio L; Castillo Barradas M; Schinoni MI; Bessone F; Contreras F; Nazal L; Sanchez A; García M; Brutti J; Cabrera MC; Miranda-Zazueta G; Rojas G; Cattaneo M; Castro-Narro G; Rubinstein F; Silva MO
    Ann Hepatol; 2021; 25():100350. PubMed ID: 33864948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the editor "Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia".
    Ramos-Vera CA; Motta JC
    Biomedica; 2021 Jun; 41(2):374-377. PubMed ID: 34214276
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19: a fatal case of acute liver failure associated with SARS-CoV-2 infection in pre-existing liver cirrhosis.
    Ihlow J; Seelhoff A; Corman VM; Gruber AD; Dökel S; Meinhardt J; Radbruch H; Späth-Schwalbe E; Elezkurtaj S; Horst D; Herbst H
    BMC Infect Dis; 2021 Sep; 21(1):901. PubMed ID: 34479499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis.
    Xiao Y; Pan H; She Q; Wang F; Chen M
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):528-529. PubMed ID: 32197093
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19.
    Ibáñez-Samaniego L; Bighelli F; Usón C; Caravaca C; Fernández Carrillo C; Romero M; Barreales M; Perelló C; Madejón A; Marcos AC; Albillos A; Fernández I; García-Samaniego J; Calleja JL; Bañares R
    J Infect Dis; 2020 Aug; 222(5):726-733. PubMed ID: 32563190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and Cirrhosis: A Combination We Must Strive to Prevent.
    Su F
    Gastroenterology; 2021 Nov; 161(5):1371-1373. PubMed ID: 34453892
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors in hospitalized HIV-positive patients with COVID-19: correspondence.
    Lee YT; Wang PH; Chen CC; Chen SC
    QJM; 2023 Sep; 116(8):719-720. PubMed ID: 37216918
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection.
    Guler-Margaritis S; Mercan-Stanciu A; Toma L; Rusie D; Isac T; Dodot M; Zgura A; Bacalbasa N; Haineala B; Badiu DC; Serban D; Iliescu EL
    In Vivo; 2021; 35(6):3377-3383. PubMed ID: 34697172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to: Prognostic factors in hospitalized HIV-positive patients with COVID-19: correspondence.
    Moreno-Torres V; Soriano V
    QJM; 2023 Sep; 116(8):721-722. PubMed ID: 37216907
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.
    Mendizabal M; Piñero F; Ridruejo E; Anders M; Silveyra MD; Torre A; Montes P; Urzúa A; Pages J; Toro LG; Díaz J; Gonzalez Ballerga E; Miranda-Zazueta G; Peralta M; Gutiérrez I; Michelato D; Venturelli MG; Varón A; Vera-Pozo E; Tagle M; García M; Tassara A; Brutti J; Ruiz García S; Bustios C; Escajadillo N; Macias Y; Higuera-de la Tijera F; Gómez AJ; Dominguez A; Castillo-Barradas M; Contreras F; Scarpin A; Schinoni MI; Toledo C; Girala M; Mainardi V; Sanchez A; Bessone F; Rubinstein F; Silva MO
    Ann Hepatol; 2021; 21():100298. PubMed ID: 33359234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 in patients with cirrhosis: understanding adverse impact.
    Sharma S; Elhence A; Vaishnav M; Kumar R; Shalimar
    Gut; 2021 Jul; 70(7):1409. PubMed ID: 32826307
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of liver cirrhosis on the clinical outcomes of patients with COVID-19: a nationwide cohort study of Korea.
    Jeon D; Son M; Choi J
    Korean J Intern Med; 2021 Sep; 36(5):1092-1101. PubMed ID: 34399573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study.
    Xiao Y; Wu D; Shi X; Liu S; Hu X; Zhou C; Tian X; Liu H; Long H; Li Z; Wang J; Tan T; Xu Y; Chen B; Liu T; Zhang H; Zheng S; Hu S; Song J; Tang J; Song J; Cheng Z; Xu W; Shen Y; Yu W; Xu Y; Li J; Zhou J; Wang F; Chen M
    Virulence; 2021 Dec; 12(1):1199-1208. PubMed ID: 33870852
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
    Bozio CH; Grannis SJ; Naleway AL; Ong TC; Butterfield KA; DeSilva MB; Natarajan K; Yang DH; Rao S; Klein NP; Irving SA; Dixon BE; Dascomb K; Liao IC; Reynolds S; McEvoy C; Han J; Reese SE; Lewis N; Fadel WF; Grisel N; Murthy K; Ferdinands J; Kharbanda AB; Mitchell PK; Goddard K; Embi PJ; Arndorfer J; Raiyani C; Patel P; Rowley EA; Fireman B; Valvi NR; Griggs EP; Levy ME; Zerbo O; Porter RM; Birch RJ; Blanton L; Ball SW; Steffens A; Olson N; Williams J; Dickerson M; McMorrow M; Schrag SJ; Verani JR; Fry AM; Azziz-Baumgartner E; Barron M; Gaglani M; Thompson MG; Stenehjem E
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1539-1544. PubMed ID: 34735425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.
    Porta-Etessam J; Núñez-Gil IJ; González García N; Fernandez-Perez C; Viana-Llamas MC; Eid CM; Romero R; Molina M; Uribarri A; Becerra-Muñoz VM; Aguado MG; Huang J; Rondano E; Cerrato E; Alfonso E; Mejía AFC; Marin F; Roubin SR; Pepe M; Feltes G; Maté P; Cortese B; Buzón L; Mendez JJ; Estrada V
    Infection; 2021 Aug; 49(4):677-684. PubMed ID: 33646505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic.
    Kim D; Bonham CA; Konyn P; Cholankeril G; Ahmed A
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2664-2666.e2. PubMed ID: 34256143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for SARS-CoV-2 Infection Severity in Abu Dhabi.
    Baynouna AlKetbi LM; Nagelkerke N; Abdelbaqi H; ALBlooshi F; AlSaedi M; Almansoori S; AlNuaimi R; AlKhoori A; AlAryani A; AlShamsi M; Kayani F; Alblooshi N; AlKhajeh S; AlFalahi J; AlAmeri S; AlDhahei S
    J Epidemiol Glob Health; 2021 Dec; 11(4):344-353. PubMed ID: 34734381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.